# US 2006/0154234 A1 · Standard

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0154234 A1
- Document ID: US20060154234A1
- Status: Published application
- Kind: A1
- Application number: 10/563,820
- Filed: 2004-07-08
- Published: 2006-07-13
- Earliest claimed: 2003-07-08
- Inventors: Lars Winther; Kunt Pll
- Web page: https://patentgrep.com/patent/US20060154234A1

## CPC

- G01N 33/5005: {involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025)}
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C12Q 1/6841: In situ hybridisation
- G01N 1/36: Embedding or analogous mounting of samples
- G01N 33/54346: {Nanoparticles}
- G01N 33/54353: {with ligand attached to the carrier via a chemical coupling agent (coatings G01N33/54393)}
- G01N 33/96: involving blood or serum control standard
- G01N 2001/2893: {Preparing calibration standards}
- G01N 2496/00: Reference solutions for assays of biological material
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Disclosed is a reference standard for a detectable entity, the reference standard comprising a support medium, such as an embedding medium, a compact particle having a compact shape with a quantity of detectable entity coupled thereto and supported by the medium, in which the compact particle is a biological, such as a cellular compact particle. We also disclose a reference standard for a detectable entity, the reference standard comprising a support medium, such as an embedding medium, a compact particle having a compact shape with a quantity of detectable entity coupled thereto and supported by the medium, in which the compact particle is a non-biological compact particle, such as a non-cellular compact particle having cell-like dimensions, preferably less than 1.5 mm.

## Claims

### Claim at position 1

-87. (canceled)

### Claim 88

A reference standard for a detectable entity, the reference standard comprising
a support medium and
a compact particle comprising a quantity of detectable entity attached to the compact particle and supported by the medium.

### Claim 89 (depends on 88)

The reference standard according to claim 88, wherein the compact particle is a biological compact particle.

### Claim 90 (depends on 88)

The reference standard according to claim 88, in which the compact particle comprises a cell.

### Claim 91 (depends on 88)

The reference standard according to claim 88, in which the compact particle comprises a cellular organelle.

### Claim 92 (depends on 88)

The reference standard according to claim 88, in which the detectable entity is derived from a cell, tissue, organ, or organism, and is indicative of a disease or condition.

### Claim 93 (depends on 88)

The reference standard according to claim 88, wherein the compact particle is a non-biological compact particle.

### Claim 94 (depends on 88)

The reference standard according to claim 88, in which the compact particle comprises a microbead or a micelle.

### Claim 95 (depends on 88)

The reference standard according to claim 88, in which a detectable amount of the detectable entity is present in one or more defined regions of the reference standard.

### Claim 96 (depends on 95)

The reference standard according to claim 95, in which the defined region is a cross section of the reference standard.

### Claim 97 (depends on 88)

The reference standard according to claim 88, in which the detectable entity is covalently attached to the compact particle.

### Claim 98 (depends on 88)

The reference standard according to claim 88, in which the support medium comprises an embedding medium in which the detectable entity is embedded.

### Claim 99 (depends on 88)

The reference standard according to claim 88, in which the detectable entity comprises an antigen, epitope, peptide, polypeptide, protein, nucleic acid, or combination thereof.

### Claim 100 (depends on 88)

The reference standard according to claim 88, in which the presence of the detectable entity is revealable by binding to a binding agent.

### Claim 101 (depends on 88)

The reference standard according to claim 88, wherein the embedding medium has a box shape and the compact particle is a cell.

### Claim 102 (depends on 88)

The reference standard according to claim 88, comprising two or more compact particles each comprising different amounts of detectable entity.

### Claim 103 (depends on 88)

The reference standard according to claim 88, in which the reference standard comprises a plurality of areas comprising the detectable entity at different densities.

### Claim 104 (depends on 103)

The reference standard according to claim 103, further comprising a control, which control comprises a compact particle with substantially no detectable entity.

### Claim 105 (depends on 88)

A kit comprising: (a) the reference standard according to claim 88 or a section of said reference standard; and (b) a binding agent capable of specific binding to the detectable entity of the reference standard.

### Claim 106 (depends on 105)

The kit according to claim 105, further comprising a therapeutic agent capable of treating or alleviating at least one symptom of a disease or condition in an individual.

### Claim 107 (depends on 106)

The kit according to claim 106, in which one or both of the binding agent and the therapeutic agent comprise an antibody against the detectable entity.

### Claim 108

A method of comparing the amount of a detectable entity in a biological sample with the amount in a reference standard, the method comprising:
(a) providing a biological sample and obtaining a first signal indicative of the amount of detectable entity in the biological sample;
(b) providing a reference standard or section thereof;
(c) obtaining a second reference signal indicative of the amount of detectable entity in the reference standard or section thereof;
(d) comparing the first signal obtained in (a) against the second reference signal obtained in (c); and optionally
(e) quantitating the first signal and the second reference signal;
wherein the reference standard comprises a support medium and a compact particle with a quantity of detectable entity attached thereto and supported by the medium.

### Claim 109 (depends on 108)

The method of claim 108, in which the biological sample comprises a cell, tissue, or organ of an individual suspected of suffering from or susceptible to a disease or condition.

### Claim 110 (depends on 108)

The method of claim 108, wherein the method is employed to diagnose an individual as suffering from or as susceptible to a disease or condition if the amount of detectable entity in the biological sample is similar to or greater than the amount of detectable entity in the reference standard.

### Claim 111 (depends on 88)

A method of assessing the effectiveness of a procedure, the method comprising:
(a) providing a reference standard according to claim 88, in which a detectable property of the detectable entity changes as a result of the procedure;
(b) performing the procedure on the reference standard; and
(c) detecting a change in the detectable property of the detectable entity.

### Claim 112 (depends on 111)

The method of claim 111, in which the procedure is chosen from in situ hybridization, immunohistochemistry, deparaffination, antigen retrieval, blocking, endogenous biotin blocking, endogenous enzyme blocking, washing, incubation with a staining agent, and incubation with a binding agent.

### Claim 113 (depends on 112)

The method of claim 112, in which the procedure is antigen retrieval and the change in the detectable property of the detectable entity is masking or unmasking of one or more epitopes.

### Claim 114 (depends on 112)

The method of claim 112, in which the procedure is deparaffination and the change in the detectable property of the detectable entity is a change in the amount of detectable entity present following the deparaffination.

### Claim 115

A modified cell comprising a detectable entity attached to a cell or component thereof, which cell does not express the detectable entity.

### Claim 116

A method of establishing a cellular distribution of detectable entity in a reference standard, the method comprising providing a cell or component thereof which does not express a detectable entity, attaching a quantity of detectable entity to the cell or component thereof, and supporting the cell or component thereof in a support medium.
